Susan Yonemura

Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light‐based photochemical treatment

R. Bowen, S. Keil, I. Ragan, 2020, Vox sanguinis.

Mirasol pathogen reduction technology treatment of human whole blood does not induce acute lung injury in mice

B. Mallavia, M. Looney, S. Marschner, 2017, PloS one.

Preservation of neutralizing antibody function in COVID‐19 convalescent plasma treated using a riboflavin and ultraviolet light‐based pathogen reduction technology

Taru S. Dutt, Marcela Henao-Tamayo, R. Goodrich, 2021, medRxiv.

Improving the safety of whole blood-derived transfusion products with a riboflavin-based pathogen reduction technology.

H. Pidcoke, R. Goodrich, S. Keil, 2017, Blood transfusion = Trasfusione del sangue.

A pilot study to assess the hemostatic function of pathogen‐reduced platelets in patients with thrombocytopenia

S. Ostrowski, P. Johansson, R. Goodrich, 2013, Transfusion.

Red Blood Cells Derived from Whole Blood Treated with Riboflavin and UV Light Maintain Adequate Cell Quality through 21 Days of Storage

R. Goodrich, S. Marschner, N. Hovenga, 2019, Transfusion Medicine and Hemotherapy.